Physician
Signe Ladegaard Harder
Department of Oncology, Odense University Hospital
Projekt styring | ||
Projekt status | Active | |
Data indsamlingsdatoer | ||
Start | 01.02.2016 | |
Slut | 01.04.2018 | |
Nausea and vomiting (N/V) are among the worst symptoms in patients with advanced cancer. The risk of N/V depends on several factors and is in the literature described to vary between 6-68 % in these patients. Despite continuing progress in the treatment of chemotherapy-induced nausea and vomiting during the last 30 years, the incidence and severity of N/V are roughly unchanged in patients with advanced cancer receiving palliative care. Evidence regarding the effect of antiemetic treatment for cancer patients in palliative care is sparse. The most recently published reviews conclude that no guidelines can be established based on the present level of evidence, and that new research is urgently needed.
In summary, the burden of N/V is very significant and N/V can, if untreated, lead to rapid deterioration in this old and fragile group of patients. The evidence base for treatment is minimal. Research in the treatment of N/V in palliative care therefore seems highly warranted, and these studies will have the potential to create important new knowledge.
Recruited from home, hospice or hospital, 5 Danish departments.
Primary criteria:
Advanced cancer with no curable treatment options
Age 18 years or more
Ability to read and understand the forms required for the study
Life-expectancy more than 2 weeks
No abdominal or brain surgery within the last 2 weeks or exposure to general anesthesia within the last 4 days.
No chemotherapy or radiation therapy within the last 4 weeks
Data originating from questionnaires and medical records. No biological material.
Bispebjerg Hospital
Zealand University Hospital
Department of Palliative Care, Zealand University Hospital
Aarhus University Hospital
Sydvestjysk Sygehus, Esbjerg